Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MDEChem is a specialized biotechnology company that focuses on the design, synthesis, and supply of stable isotope-labeled compounds, particularly deuterated building blocks. Headquartered in San Diego, California, the company serves the global pharmaceutical and life sciences industries by providing high-quality intermediates for drug discovery and development. Their core expertise lies in the strategic incorporation of deuterium into small molecules to assist researchers in evaluating metabolic pathways and improving pharmacokinetic properties. MDEChem offers an extensive catalog of off-the-shelf labeled reagents alongside custom synthesis services for complex organic molecules. By enabling the exploration of deuterated drug candidates, the company plays a vital role in the advancement of next-generation therapeutics with optimized metabolic profiles.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MDEChem.